The catheters are reprocessed to be reused with full safety guarantees for both patients and professionals.

This initiative is an example of the transition towards a circular economy in the healthcare sector, reducing the environmental impact of these devices and enhancing the efficient management of resources.

The incorporation of the Versius robot increases the number of robotic surgeries at the hospital to 1,200 per year and strengthens excellence in complex oncological surgery.

A joint study by Hospital de Bellvitge and Hospital Sant Joan de Déu has confirmed that two people with the same genetic defect can experience very different forms of a hereditary eye disease. This discovery, recently published in the journal Genes, opens new perspectives for designing more personalized treatments for patients with hereditary retinal dystrophy.

It also led tissue donation among Catalan centres and living-donor kidney transplants across Spain.

Last year, a total of 285 kidneys, liver, and heart transplants were performed, thanks to the generosity of families and the dedication of healthcare professionals. Thanks to the generosity of families and the dedication of healthcare professionals.

Mavacamten is the first available cardiac myosin inhibitor that specifically addresses the pathophysiological mechanisms of obstructive hypertrophic cardiomyopathy (HCM). This innovative and personalized therapy offers a new therapeutic target that was previously unattainable, with the potential to prevent invasive procedures in the treatment of this condition.

With the new unit, Bellvitge continues to roll out a new model of mental health care that enhances patient autonomy and eliminates the stigma surrounding these conditions.

The goal is to provide a comprehensive approach, with flexible, personalized, and close care, involving patients and their families in the process.